We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$16B
AUM Growth
+$1.49B
Cap. Flow
+$904M
Cap. Flow %
5.66%
Top 10 Hldgs %
21.47%
Holding
2,613
New
47
Increased
594
Reduced
1,043
Closed
153

Top Buys

Rank Stock Value
1
BHF icon
Brighthouse Financial
BHF
+$1.32B
2
BAC icon
Bank of America
BAC
+$109M
3
HON icon
Honeywell
HON
+$51.5M
4
DD icon
DuPont de Nemours
DD
+$40.3M
5
AIG icon
American International
AIG
+$27.1M

Top Sells

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$211M
2
CVS icon
CVS Health
CVS
+$39.7M
3
DD
Du Pont De Nemours E I
DD
+$36.9M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$29.2M
5
RAI
Reynolds American Inc
RAI
+$27.3M

Sector Composition

Rank Sector Weight
1 Financials 23.16%
2 Technology 13.54%
3 Healthcare 11.1%
4 Industrials 10.02%
5 Consumer Discretionary 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARRY
1051
DELISTED
Array Biopharma Inc
ARRY
$1.46M 0.01%
118,685
-491
-0.4% -$4.56K
SEM
1052
DELISTED
Select Medical
SEM
$1.46M 0.01%
141,052
– –
AMN icon
1053
AMN Healthcare
AMN
$1.34B
$1.46M 0.01%
31,840
– –
BGS icon
1054
B&G Foods
BGS
$291M
$1.45M 0.01%
45,446
– –
VIAV icon
1055
Viavi Solutions
VIAV
$10.6B
$1.44M 0.01%
152,456
-11,488
-7% -$120K
IRWD icon
1056
Ironwood Pharmaceuticals
IRWD
$714M
$1.44M 0.01%
108,991
– –
EGBN icon
1057
Eagle Bancorp
EGBN
$877M
$1.44M 0.01%
21,425
– –
MTOR
1058
DELISTED
MERITOR, Inc.
MTOR
$1.44M 0.01%
55,167
– –
MMSI icon
1059
Merit Medical Systems
MMSI
$5.45B
$1.43M 0.01%
33,719
– –
AMKR icon
1060
Amkor Technology
AMKR
$14.3B
$1.43M 0.01%
135,102
+67,254
+99% +$644K
AZTA icon
1061
Azenta
AZTA
$1.47B
$1.43M 0.01%
46,923
– –
POWI icon
1062
Power Integrations
POWI
$3.57B
$1.42M 0.01%
38,906
-402
-1% -$14.7K
MDR
1063
DELISTED
McDermott International
MDR
$1.42M 0.01%
65,180
-321
-0.5% -$6.44K
REXR icon
1064
Rexford Industrial Realty
REXR
$8.11B
$1.42M 0.01%
49,577
+947
+2% +$27.2K
UCB
1065
United Community Banks
UCB
$4.43B
$1.42M 0.01%
49,703
– –
LOXO
1066
DELISTED
Loxo Oncology, Inc
LOXO
$1.42M 0.01%
15,382
+1,726
+13% +$134K
ABCO
1067
DELISTED
Advisory Board Co
ABCO
$1.42M 0.01%
26,388
-349
-1% -$18.8K
UA icon
1068
Under Armour Class C
UA
$2.25B
$1.41M 0.01%
93,984
-469
-0.5% -$7.9K
DK icon
1069
Delek US
DK
$4.12B
$1.41M 0.01%
52,756
+8,198
+18% +$205K
RARE icon
1070
Ultragenyx Pharmaceutical
RARE
$2.6B
$1.41M 0.01%
26,473
– –
GLP icon
1071
Global Partners
GLP
$1.72B
$1.41M 0.01%
80,741
– –
BYD icon
1072
Boyd Gaming
BYD
$6.03B
$1.4M 0.01%
53,904
-3,784
-7% -$97.9K
CSOD
1073
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$1.4M 0.01%
34,578
– –
CCOI icon
1074
Cogent Communications
CCOI
$530M
$1.39M 0.01%
28,454
– –
VGR
1075
DELISTED
Vector Group Ltd.
VGR
$1.39M 0.01%
105,552
-1
-0% -$13
41 42
43
44 45

Similar funds

RM
Rudius Management New York $358M AUM 12.23% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
KLWA
Kelly Lawrence W & Associates Pasadens, California $360M AUM 16.9% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s Q3 2017 Portfolio in Review

As of Q3 2017, Metropolitan Life Insurance Company (MetLife) held 2,613 positions worth $16B, up 10% from $14.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Metropolitan Life Insurance Company (MetLife) deployed $904M of net new capital in Q3 2017, opening 47 new positions and adding to 594 existing holdings. Its largest new stake was Brighthouse Financial: 23,194,796 shares worth $1.36B.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $211M trimmed.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2017 buy was Brighthouse Financial: 23,194,796 shares worth $1.36B.
  • Metropolitan Life Insurance Company (MetLife) added most to Bank of America in Q3 2017, an estimated $109M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2017 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $211M.
  • Metropolitan Life Insurance Company (MetLife) fully exited CVS Health in Q3 2017, selling an estimated $39.7M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 21% of its $16B portfolio in Q3 2017.
  • Metropolitan Life Insurance Company (MetLife) opened 47 new positions and closed 153 in Q3 2017.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 10% quarter-over-quarter to $16B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2017, filed 14 Nov 2017.